Skip to NavigationSkip to content

News

0
US-based drug delivery systems company Aptar Pharma has released its first metal-free, multidose nasal spray. APF Futurity delivers multidose nasal...
0
Amgen’s Amjevita (adalimumab-atto) has just launched on the US market, meaning it becomes the first biosimilar to reference the blockbuster drug...
0
A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) bankruptcy petition, which aimed to transfer...
0
Clinical-stage biopharmaceutical company, First Wave BioPharma, has announced that it is planning to begin its phase 2 clinical trial of an enhanced...

Features

Pharmafocus journalists Ana Ovey and Lina Adams made their way to Zurich for Veeva’s annual R&D and Quality Summit 2022. Here...